Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the κ-opioid receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the κ-opioid receptor

Published:2008-07 Issue:2 Volume:197 Page:114-123
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Finley Matthew J.,Chen Xiaohong,Bardi Guiseppe,Davey Penny,Geller Ellen B.,Zhang Lily,Adler Martin W.,Rogers Thomas J.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference69 articles.

1. Chemoattractant receptor cross-desensitization. [Review] [52 refs];Ali;J. Biol. Chem.,1999

2. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H;Alicea;J. Neuroimmunol.,1996

3. Human chemokines: an update. [Review] [181 refs];Baggiolini;Annu. Rev. Immunol.,1997

4. The chemokine SDF1 regulates migration of dentate granule cells;Bagri;Development,2002

5. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes;Balabanian;J. Biol. Chem.,2005

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis;Journal of Allergy and Clinical Immunology;2023-10

2. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies;Frontiers in Pharmacology;2022-06-20

3. CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy;Cancers;2022-05-06

4. Chemokines, cytokines and substance use disorders;Drug and Alcohol Dependence;2021-03

5. New and emerging treatments for inflammatory itch;Annals of Allergy, Asthma & Immunology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3